XML 43 R30.htm IDEA: XBRL DOCUMENT v3.22.4
Operating Segments and Related Information
 12 Months Ended
Dec. 31, 2022
Segment Reporting [Abstract]  
Operating Segments and Related Information
20. Operating Segments and Related Information

The Company currently has one primary reportable geographic segment - United States and primarily all revenue is derived in the United States. The Company has three reportable operating segments, plus our Other segment, based on management’s organization of the enterprise - Infrastructure, Life Sciences, Spectrum, and Other. We also have included a Non-operating Corporate segment. All inter-segment revenues are eliminated on consolidation.

The Company's revenue concentrations of 10% and greater for the periods indicated were as follows:

Years Ended December 31,
Segment20222021
Customer AInfrastructure23.8%13.9%

Summarized financial information with respect to the Company’s operating segments for the periods indicated is as follows (in millions):

 Years Ended December 31,
 20222021
Revenue
Infrastructure
$1,594.3 $1,159.7 
Life Sciences4.3 3.5 
Spectrum38.7 42.0 
Total revenue$1,637.3 $1,205.2 

 Years Ended December 31,
 20222021
Income (loss) from operations
Infrastructure
$57.5 $35.2 
Life Sciences(20.1)(19.9)
Spectrum(3.8)(0.8)
Other(0.6)(2.0)
Non-operating Corporate(19.6)(23.1)
Total income (loss) from operations$13.4 $(10.6)

 Years Ended December 31,
Reconciliation of the consolidated segment income (loss) from operating consolidated loss from continuing operations before income taxes 20222021
Income (loss) from operations$13.4 $(10.6)
Interest expense(52.0)(59.1)
Loss on extinguishment of debt— (12.5)
Loss from equity investees(1.3)(2.8)
Other (expense) income, net(1.2)4.3 
Loss from continuing operations before income taxes$(41.1)$(80.7)
 Years Ended December 31,
 20222021
Depreciation and Amortization
Infrastructure
$21.0 $19.1 
Infrastructure recognized within cost of revenue
15.0 12.2 
Total Infrastructure36.0 31.3 
Life Sciences0.3 0.2 
Spectrum5.8 6.0 
Non-operating Corporate0.1 0.1 
Total depreciation and amortization$42.2 $37.6 

Years Ended December 31,
 20222021
Capital Expenditures (*)
Infrastructure
$16.5 $18.3 
Life Sciences0.8 0.5 
Spectrum3.3 5.3 
Non-operating Corporate0.1 — 
Total$20.7 $24.1 
(*) The above capital expenditures exclude assets acquired under capital lease and other financing obligations.

December 31,
 20222021
Investments
Infrastructure
$— $0.7 
Life Sciences7.6 10.2 
Other51.9 45.1 
Total$59.5 $56.0 

December 31,
20222021
Equity Method Investments (included in Investments above)
Infrastructure$— $0.7 
Life Sciences3.0 4.2 
Other40.6 33.9 
Total$43.6 $38.8 

December 31,
 20222021
Total Assets
Infrastructure
$879.3 $786.4 
Life Sciences15.4 22.0 
Spectrum188.2 198.9 
Other53.6 48.0 
Non-operating Corporate15.2 25.3 
Total$1,151.7 $1,080.6